Hui Liu

Hui Liu

Auto-generated profile, based on publicly available information

Hui Liu

Henan Key Laboratory of Immunology and Targeted Drug, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Medical Technology, Xinxiang Medical University, Xinxiang, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
QFQi Feng
Qi Feng
XYXiaoyue Yu
Xiaoyue Yu
YQYingjin Qiao
Yingjin Qiao
SPShaokang Pan
Shaokang Pan
RWRui Wang
Rui Wang
YYYang Yang
Yang Yang
Acute kidney injury (AKI), a common and serious clinical kidney syndrome with high incidence and mortality, is caused by multiple pathogenic factors, such as ischemia, nephrotoxic drugs, oxidative stress, inflammation, and urinary tract obstruction. Cell death, which is divided into several types, is critical for normal growth and development and maintaining dynamic balance. Ferroptosis, an iron-dependent nonapoptotic type of cell death, is characterized by iron overload, reactive oxygen species accumulation, and lipid peroxidation. Recently, growing evidence demonstrated the important role of ferroptosis in the development of various kidney diseases, including renal clear cell carcinoma, diabetic nephropathy, and AKI. However, the exact mechanism of ferroptosis participating in the initiation and progression of AKI has not been fully revealed. Herein, we aim to systematically discuss the definition of ferroptosis, the associated mechanisms and key regulators, and pharmacological progress and summarize the most recent discoveries about the role and mechanism of ferroptosis in AKI development. We further conclude its potential therapeutic strategies in AKI.

6 April 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
HLHui Liu
Hui Liu
ZMZiyu Meng
Ziyu Meng
HWHesuiyuan Wang
Hesuiyuan Wang
SZShuo Zhang
Shuo Zhang
ZHZhen Huang
Zhen Huang
ZHZhangyong Hong
Zhangyong Hong

29 May 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
XCXing Chen
Xing Chen
YYYang Yang
Yang Yang
BHBingjie Han
Bingjie Han
ZZZheng Zhou
Zheng Zhou
CXCongying Xu
Congying Xu
YLYi Luan
Yi Luan

10 July 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HLHui Liu
Hui Liu
MPMengmeng Pan
Mengmeng Pan
YLYumeng Li
Yumeng Li
ZHZhen Huang
Zhen Huang
HLHanying Li
Hanying Li
HWHui Wang
Hui Wang
Mitochondria are bilayer membrane organelles with basic metabolic activity. They are considered hubs for biosynthesis, bioenergy, and signaling functions, coordinating major biological pathways. Mitochondria are coupled to the oxidation of fatty acids and pyruvate through electron transport chains and have historically been considered the primary source of cellular energy. Recent studies have depicted that mitochondria are centers that promote inflammatory responses and play a crucial role in combating pathogenic infections. Moreover, mitochondria provide the basis for tumor synthesis metabolism, control redox and calcium homeostasis, participate in transcriptional regulation, and control cell death. Mitochondria are involved in all steps of tumorigenesis. This review discusses the relationship between mitochondria (including mitochondrial metabolism and mitophagy) and tumors, and the relationship between mtDNA and inflammation, as well as its clinical application in inflammatory diseases. More importantly, the application and targeted treatment strategies provide more opportunities for the development of new anticancer drugs.

20 August 2024 in ACS Materials Letters
Verified
Journal Article
Closed access
YSYuna Shang
Yuna Shang
FZFan Zhang
Fan Zhang
ZWZhongyan Wang
Zhongyan Wang
HLHongjing Luo
Hongjing Luo
HLHui Liu
Hui Liu
CLChunju Li
Chunju Li

14 November 2025 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YWYiwei Wang
Yiwei Wang
CZChengyan Zhang
Chengyan Zhang
HWHaonan Wang
Haonan Wang
YZYali Zhou
Yali Zhou
YYYuanbo Yu
Yuanbo Yu
CGChuansha Gu
Chuansha Gu
Neutrophil extracellular traps (NETs) are web‑like structures released by activated neutrophils, composed of DNA, histones and antimicrobial proteins. Although initially discovered for their role in innate immunity, NETs are also closely associated with the pathogenesis of chronic hepatitis and hepatocellular carcinoma (HCC). The present review, which analyzes the latest research from databases such as PubMed and Web of Science, focuses on the formation of NETs, their roles in hepatitis (including hepatitis B, non-alcoholic steatohepatitis and ischemia‑reperfusion injury) and their contributions to the initiation, progression and metastasis of HCC. The present review aimed to systematically elucidate the role of NETs in the transition from hepatitis to HCC, with a focus on underlying molecular mechanisms and potential therapeutic implications. The current findings suggest that targeting NET formation or function through inhibition of peptidylarginine deiminase 4, neutrophil elastase, DNase I or related signaling pathways may represent a promising therapeutic strategy to suppress inflammation‑driven hepatocarcinogenesis and improve outcomes for patients with HCC. However, further validation is required to translate these findings into clinical applications.